Anglo-French Drugs & Industries unveils respiratory care products
The range that the company launched has already received approval from Drug Control Department.
Mumbai: Anglo-French Drugs & Industries Limited has announced that it has launched new products in the pharma division: - AFD Pulmo Range in respiratory care. The range of the products that are launched are AFD-PULMO-AZI: anti-infective: azithromycin molecule which is one of the preferred molecules in respiratory tract infections. AFD-PULMO-LS: Cough syrup for productive cough which is the largest segment in cough preparations. AFD-PULMO-A2: Combination of Acebrophylline and Acetylcysteine a fast-growing segment related to severe cases of bronchitis especially when there is hypersecretion of mucus in the respiratory tract leading to breathing disorders.
The range that the company launched has already received approval from Drug Control Department.
Mr. Abhay Kanoria, Chairman & Managing Director, Anglo French Drugs & Industries Limited, "We have launched these products in India keeping in mind the respiratory problems that have arisen among children and adults with the emergence of covid. Our product is of superior quality that will keep us ahead in the market among the other players in the pharma industry. We are very positive about the growth of our pharma division with the launch of our new products in the Pulmo range."
AFD Pulmo -AZI is available in two strengths: 500mg will be sold at a maximum retail price of Rs.125 per strip of 5 tabs and 250mg for Rs. 125 per strip of 10 tabs. AFD-PULMO-LS will be sold at a maximum price of Rs.109 for 100 ml bottle. AFD-PULMO-A2 will be sold at a maximum retail price of Rs.180 for strip of 10 tabs.
Read also: Granules India net profit up 80 percent at Rs 145 crore in Q2
Anglo-French Drugs & Industries Limited is a pharmaceutical company established in 1923. The company has market-leading brands in nutraceuticals and the cough & cold segment. It currently markets about 100 products.
Read also: Glenmark Pharma unveils Teneligliptin plus Dapagliflozin FDC for type 2 diabetes
